Cartesian Therapeutics, Inc.RNACNASDAQ
Loading
EBITDA as a percentage of revenue
Percentile
P18
Within normal range
vs 3Y Ago
-86.2x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -3099.93% | -1487.5% |
| 2024 | -195.27% | +78.4% |
| 2023 | -903.84% | -2613.3% |
| 2022 | 35.96% | +693.2% |
| 2021 | -6.06% | +98.5% |
| 2020 | -395.21% | +49.1% |
| 2019 | -775.86% | +88.9% |
| 2018 | -6962.02% | +77.3% |
| 2017 | -30611.11% | -7144.3% |
| 2016 | -422.55% | - |